Articles From: GelStat Corporation Reports Preliminary Third Quarter Revenue and Updates Guidance for the Fourth Quarter to First Reliance Announces Strong 3rd Quarter Results


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024641-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/26/11G024641/Logo1-1647777922.jpg PALM CITY, FL--(Marketwired - October 27, 2014) - GelStat Corporation (PINKSHEETS: GSAC), a fully integrated consumer healthcare company engaged in the development, marketing, branding and manufacturing of innovative over-the-counter (OTC) consumer healthcare products, reports preliminary third quarter revenue and updates guidance for the fourth quarter.
Sign-up for GelStat Corporation Reports Preliminary Third Quarter Revenue and Updates Guidance for the Fourth Quarter investment picks
2014/10/27
--Agreement Includes Integration of Electronic Medical Records--
Sign-up for MinuteClinic and Lifespan Agree to Clinical Collaboration in Rhode Island investment picks
http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153873&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call investment picks
Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended September 30, 2014.
Sign-up for Allergan Reports Third Quarter 2014 Operating Results investment picks
THE WOODLANDS, Texas, Oct.
Sign-up for LGI Homes to Host 2014 Third Quarter Earnings Conference Call investment picks
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its third quarter ended September 30, 2014 before market trading hours on Thursday, November 6, 2014.
Sign-up for Harvard Apparatus Regenerative Technology Schedules Release of Third Quarter 2014 Financial Results and Investor Teleconference for November 6, 2014 investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2014.
Sign-up for Merck Announces Third-Quarter 2014 Financial Results investment picks
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that the ARROW® EZ-IO® Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014.
Sign-up for Teleflex Announces ARROW® EZ-IO® Vascular Access System Reaches 3 Million Needles Sold Milestone investment picks
2014/10/27
SHENZHEN, China , Oct.
Sign-up for CNIT Entered Strategic Partnership with Pengfeng Investment on Automobile New Media Platform investment picks
GREAT NECK, N.Y., Oct.
Sign-up for Manhattan Bridge Capital, Inc. to Report Results for the Third Quarter on October 30, 2014 investment picks
CEVA's flagship communications DSP delivers outstanding performance, enabling the highest capacity, most flexible G.fast modems ever conceived MOUNTAIN VIEW, Calif.
Sign-up for Sckipio Licenses and Deploys CEVA-XC Communications DSP in World's First G.fast Chipsets investment picks
2014/10/27
Opus Bank ("Opus") (NASDAQ: “OPB”) announced today net income of $7.7 million, or $0.24 per diluted share, for the third quarter of 2014 compared with $10.3 million, or $0.32 per diluted share, for the second quarter of 2014 and $109.4 million, or $3.79 per diluted share, for the third quarter of 2013.
Sign-up for Opus Bank Announces Third Quarter 2014 Results investment picks
2014/10/27
More than 30,000 items will be sold at 50+ Ritchie Bros .
Sign-up for Ritchie Bros. global equipment highlights: heavy construction & mining investment picks
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today provided an update on its discussions with the U.S. Food and Drug Administration (FDA) regarding its planned New Drug Application (NDA) submission for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD). In meeting minutes received last week from a Type B Pre-NDA meeting that took place in September 2014, the FDA provided updated guidance regarding the specific data to be included as part of, or at the time of, Sarepta’s NDA submission.
Sign-up for Sarepta Therapeutics Announces Regulatory Update on Eteplirsen investment picks
Agenus Inc. (NASDAQ: AGEN) will report its third quarter 2014 financial results before the market opens on Friday, October 31, 2014.
Sign-up for Agenus to Report Third Quarter 2014 Financial Results on October 31, 2014; Conference Call to Follow investment picks
http://media.marketwire.com/attachments/201211/102974_EvolvinglogoR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153883&ProfileId=051205&sourceType=1 ENGLEWOOD, CO --
Sign-up for Evolving Systems Sets Date for 2014 Third Quarter Results News Release and Conference Call investment picks
UCP, Inc. (NYSE:UCP) today announced that it will release its financial results for the third quarter ending September 30, 2014 before the market opens on Monday, November 10, 2014, and will subsequently host a conference call for investors and other interested parties beginning at 12:00 p.m. Eastern Time, 9:00 a.m. Pacific Time.
Sign-up for UCP to Host Third Quarter 2014 Earnings Conference Call investment picks
BATON ROUGE, La., Oct.
Sign-up for Investar Holding Corporation Announces 2014 Third Quarter Results investment picks
Data from Sublingual Sufentanil Development Program Highlights Analgesic Response Compared to IV Morphine in Young vs Elderly Adult Patients REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting investment picks
GAAP Diluted Earnings Per Share (DEPS) $1.54; Adjusted DEPS $1.55 Operating Cash Flow of $226 million, 25.6% of Revenue Full Year Guidance Increased SARASOTA, Fla.
Sign-up for Roper Industries Announces Record Third Quarter Results investment picks
· Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process LAVAL, Quebec , Oct.
Sign-up for Valeant Delivers Letter To Allergan Board investment picks
2014/10/27
Italian market watchdog Consob on Monday imposed a temporary short-selling ban on shares of Banca Monte dei Paschi di Siena Spa (IT:BMPS) as they sank 20% on the Milan stock exchange.
Sign-up for Italy bans short selling on Monte dei Paschi as shares slump 20% investment picks
2014/10/27
SHANGHAI , Oct.
Sign-up for SMIC and ASML Sign a Volume Purchase Agreement Worth 450 Million Euros investment picks
FLORENCE, S.C. , Oct.
Sign-up for First Reliance Announces Strong 3rd Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: GelStat Corporation Reports Preliminary Third Quarter Revenue and Updates Guidance for the Fourth Quarter to First Reliance Announces Strong 3rd Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent